Local Remodelling of Bone Fracture Healing
Local Remodelling and Mechanoregulation of Bone Fracture Healing in Healthy, Aged, and Osteoporotic Humans
1 other identifier
interventional
106
0 countries
N/A
Brief Summary
The aim of our study is to improve a mathematical model (FAE) of human bone healing using the example of the distal spoke fracture. Computer-aided strength analyzes of data from hr-pqCTs should provide information about the fracture strength and quality of the newly formed bone at defined times. Laboratory parameters from sober blood analyzes, bone remodeling markers, competitive x-rays, the course of pain, range of motion, grip strength and other easily accessible parameters should be evaluated with the above-mentioned analyzes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2015
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 17, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2019
CompletedFirst Submitted
Initial submission to the registry
February 15, 2021
CompletedFirst Posted
Study publicly available on registry
March 5, 2021
CompletedMarch 5, 2021
February 1, 2021
3.1 years
February 15, 2021
March 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Strength analysis of the distal radius fracture
The aim of our study is to create a mathematical model of human bone healing using the example of a distal radius fracture. Computer-aided strength analyzes of data from hr-pqCTs should provide information about the fracture strength and quality of the newly formed bone at defined times.(finite element analysis- FEA)
1 year
Secondary Outcomes (6)
Rate of bone density
1year
Bone remodeling markers (blood analysis)
1year
Patient Reported Outcome (function)
1 year
Patient Reported Outcome (pain)
1 year
Clinical outcome (range of motion)
1 year
- +1 more secondary outcomes
Study Arms (1)
HR-pQCT (high resolution computertomograph)
EXPERIMENTALThis arm is the inverventional group for all collected cases. No other arms are available as comparator or control. All patients are treated the same. Description of the intervention in the section "Intervention".
Interventions
In addition to determining the bone density, a quantitative bone structure analysis with measurement of the number of thickness and distribution of the trabeculae can also be carried out. In addition, the finite element analysis (FEA) allows strength models of the examined bone to be created from the data of the hr-pqCTs. In this way, the osseous consolidation of the fracture can not only be observed, but also tested for resilience with the help of mathematical models.
Bone remodeling blood marker: S-CTX (Crosslaps), S-TRA5b ( tartrate-resistant acid phosphatase), S-PINP (Procollagen type 1 amino-terminal propeptide), BALP, Calcium, parathyroid hormone, 25-OH-Vitamin D3 (HPLC)
Eligibility Criteria
You may qualify if:
- Age 18+
- Conservatively treated distal radius fracture
- Able and agree to sign a written consent
- Able and agree to attend the follow-up examinations
- Able to understand the national language both in writing and orally to a minimum
You may not qualify if:
- Age under 18
- Comminuted fracture
- Bilateral spoke fracture
- unstable fracture with indication for surgical treatment
- open spoke fracture
- Adjacent fractures or injuries
- Previous injury to the distal radius
- The patient cannot give consent due to physical or mental disabilities
- Patient is not available for regular check-ups (abroad)
- The patient does not have full legal capacity
- Alcohol and drug abuse
- Current treatment with steroids
- Multiple trauma
- Illnesses or disorders that restrict the movement of a hand (apoplexy, hemiparesis, neuromuscular or rheumatic disease, severe mental or metabolic diseases)
- Rheumatoid arthritis
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University Innsbrucklead
- ETH Zurichcollaborator
- University Hospital Ulmcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 15, 2021
First Posted
March 5, 2021
Study Start
December 10, 2015
Primary Completion
January 17, 2019
Study Completion
December 19, 2019
Last Updated
March 5, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share